Spots Global Cancer Trial Database for Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
Official Title: R01 CA155301: Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
Study ID: NCT01594502
Conditions
Study Description
Brief Summary: The goal of this study is to apply cutting-edge imaging approaches, incorporating machine-learning for pattern recognition and multispectral analysis, to the development and validation of intermediate endpoint biomarkers in benign tissue that characterize the response to 5α-reductase inhibitor chemoprevention as well as the risk of prostate cancer among men with negative biopsies.
Detailed Description:
Keywords
Eligibility
Minimum Age: 50 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
University of Illinois at Chicago, Chicago, Illinois, United States
Contact Details
Name: Peter H Gann, MD, ScD
Affiliation: University of Illinois at Chicago
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
